Ditemukan 17113 dokumen yang sesuai dengan query :: Simpan CSV
Nurmainah, Ahmad Fudholi, Iwan Dwiprahasto
KJKMN Vol.8, No.1
Depok : FKM UI, 2013
Indeks Artikel Jurnal-Majalah Pusat Informasi Kesehatan Masyarakat
☉
Ariqa Salsabila; Pembimbing: Dien Anshari; Penguji: Evi Martha, Fitrianindita
Abstrak:
Read More
Indikator penderita obat hipertensi berobat teratur dalam IKS (Indeks Keluarga Sehat) wilayah Puskesmas Harjamukti kota Depok di tahun 2022 hanya mencapai 43,5% sehingga program PTM Hipertensi masih menjadi program utama. Penelitian ini dilakukan bertujuan untuk mengetahui gambaran kepatuhan minum obat antihipertensi di Puskesmas Harjamukti dan juga melihat faktor predisposisi, faktor pemungkin dan faktor pendorong pada kepatuhan minum obat antihipertensi. Metode penelitian yang digunakan yaitu kuantitatif dengan desain studi potong lintang yang bersifat deskriptif. Pengumpulan data dilakukan menggunakan kuesioner dengan total sampel sebanyak 150 orang pasien hipertensi di wilayah kerja Puskesmas Harjamukti. Hasil penelitian menunjukkan bahwa 64% pasien hipertensi di Puskesmas Harjamukti memiliki kepatuhan yang rendah dan hanya 16,7% dari total responden yang memiliki kepatuhan tinggi. Perlu dilakukan penyuluhan lebih mendalam terkait alat bantu kepatuhan minum obat, juga membangun sistem pengingat minum obat di Puskesmas Harjamukti.
The indicator for hypertension patients taking regular medication in the IKS (Indeks Keluarga Sehat) area of the Harjamukti Primary Health Care, Depok in 2022 only reach 43.5%, the Non-communicable Disease Hypertension program is still the main program of Harjamukti Primary Health Care. This research was conducted with the aim of knowing the description of patient’s adherence in taking antihypertensive medication at the Harjamukti Primary Health Care and also to see the predisposing factors, enabling factors and reinforcing factors in the adherence to antihypertensive medication. The research method used is quantitative with a descriptive cross-sectional study design. Data collection was carried out using a questionnaire with a total sample of 150 hypertension patients in Harjamukti Primary Health Care working area. The results showed that 64% of hypertensive patients at the Harjamukti Community Health Center had low adherence, and only 16,7% of them are having high adherence. It is necessary to provide more in-depth education regarding adherence supporting tools, as well as establishing a medication reminder system in the Harjamukti Primary Health Care.
S-11591
Depok : FKM-UI, 2024
S1 - Skripsi Pusat Informasi Kesehatan Masyarakat
☉
Bintang Sukma Dhea Fransisca Enjellita; Pembimbing: Nurhayati Adnan; Penguji: Helda, Dewi Kristanti
Abstrak:
Read More
Latar belakang: Hipertensi menjadi penyebab kematian dini tertinggi di seluruh dunia dan merupakan faktor risiko utama untuk penyakit kardiovaskular termasuk di Indonesia. Jawa Barat merupakan provinsi dengan angka prevalensi hipertensi tertinggi di Indonesia yaitu sebesar 34,4% berdasarkan hasil pengukuran tekanan darah dan sebesar 10,7% berdasarkan diagnosis dokter yang menjadikan Jawa Barat sebagai provinsi terbesar ketiga dengan prevalensi hipertensi terbanyak pada penduduk berusia ≥ 18 tahun. Dalam penanganan penyakit hipertensi, indikator terkait terapi atau pengobatan hipertensi merupakan salah satu faktor yang penting untuk diperhatikan. Data terbaru yang diperoleh dari Survei Kesehatan Indonesia (SKI) tahun 2023 menunjukkan bahwa ketidakpatuhan konsumsi obat antihipertensi di Jawa Barat mencapai 53,8% dengan 35,5% pasien tidak teratur minum obat dan 18,3% tidak minum obat sama sekali. Rendahnya kepatuhan pasien hipertensi untuk konsumsi obat antihipertensi masih menjadi masalah dalam penanganan hipertensi di Indonesia terutama di Jawa Barat. Tujuan: Penelitian ini bertujuan untuk mengetahui faktor-faktor yang berhubungan dengan ketidakpatuhan konsumsi obat antihipertensi pada pasien hipertensi berusia ≥ 18 tahun di Jawa Barat. Metode: Penelitian ini menggunakan desain studi cross-sectional dengan analisis univariat dan bivariat. Hasil: Prevalensi ketidakpatuhan konsumsi obat antihipertensi pada pasien hipertensi usia ≥ 18 tahun di Jawa Barat adalah 53,1% dengan “merasa sudah sehat” menjadi alasan tertinggi ketidakpatuhan. Faktor yang signifikan berhubungan dengan ketidakpatuhan konsumsi obat antihipertensi meliputi berusia 18 - 59 tahun (PR = 1,23; 95% CI = 1,06 - 1,47), memiliki tingkat pendidikan rendah (PR = 1,17; 95% CI = 1,09 - 1,27), tidak memiliki jaminan kesehatan (PR = 1,26; 95% CI = 1,18 - 1,36), merokok (PR = 1,12; 95% CI = 1,04 - 1,21), tidak memiliki pengetahuan terkait konsumsi obat antihipertensi (PR = 1,88; 95% CI = 1,72 - 1,97). Kesimpulan: Pemerintah perlu meningkatkan edukasi kesehatan dan menekankan pentingnya rutin mengonsumsi obat antihipertensi meskipun tidak merasakan gejala. Selain itu, diperlukan kerja sama lintas sektor untuk mendukung pencegahan ketidakpatuhan konsumsi obat antihipertensi.
Background: Hypertension is the leading cause of premature death worldwide and is a major risk factor for cardiovascular diseases, including in Indonesia. West Java is the province with the highest prevalence of hypertension in Indonesia, with a rate of 34.4% based on blood pressure measurements and 10.7% based on doctor diagnoses. This makes West Java the third largest province in terms of hypertension prevalence among individuals aged ≥ 18 years. In managing hypertension, indicators related to hypertension therapy or medication are crucial factors that need attention. Recent data from the Indonesia Health Survey (SKI) shows that non-adherence to antihypertensive medication in West Java reaches 53.8%, with 35.5% of patients taking medication irregularly and 18.3% not taking medication at all. The low level of adherence among hypertensive patients to taking antihypertensive medication remains a significant issue in hypertension management in Indonesia, particularly in West Java. Objective: This study aims to identify the factors associated with non-adherence to antihypertensive medication among hypertensive patients aged ≥ 18 years in West Java. Methods: This research used a cross-sectional study design with univariate and bivariate analyses. Results: The prevalence of non-adherence to antihypertensive medication among hypertensive patients aged ≥ 18 years in West Java is 53.1%, with “feeling healthy” being the most common reason for non-adherence. Significant factors associated with non-adherence to antihypertensive medication include: being aged 18–59 years (PR = 1.23; 95% CI = 1.06–1.47), having a low education level (PR = 1.17; 95% CI = 1.09–1.27), lacking health insurance (PR = 1.26; 95% CI = 1.18–1.36), smoking (PR = 1.12; 95% CI = 1.04–1.21), and lacking knowledge related to antihypertensive medication (PR = 1.88; 95% CI = 1.72–1.97). Conclusion: The government needs to enhance health education and emphasize the importance of regularly taking antihypertensive medication, even when no symptoms are present. Additionally, cross-sector collaboration is necessary to support the prevention of non-adherence to antihypertensive medication.
Background: Hypertension is the leading cause of premature death worldwide and is a major risk factor for cardiovascular diseases, including in Indonesia. West Java is the province with the highest prevalence of hypertension in Indonesia, with a rate of 34.4% based on blood pressure measurements and 10.7% based on doctor diagnoses. This makes West Java the third largest province in terms of hypertension prevalence among individuals aged ≥ 18 years. In managing hypertension, indicators related to hypertension therapy or medication are crucial factors that need attention. Recent data from the Indonesia Health Survey (SKI) shows that non-adherence to antihypertensive medication in West Java reaches 53.8%, with 35.5% of patients taking medication irregularly and 18.3% not taking medication at all. The low level of adherence among hypertensive patients to taking antihypertensive medication remains a significant issue in hypertension management in Indonesia, particularly in West Java. Objective: This study aims to identify the factors associated with non-adherence to antihypertensive medication among hypertensive patients aged ≥ 18 years in West Java. Methods: This research used a cross-sectional study design with univariate and bivariate analyses. Results: The prevalence of non-adherence to antihypertensive medication among hypertensive patients aged ≥ 18 years in West Java is 53.1%, with “feeling healthy” being the most common reason for non-adherence. Significant factors associated with non-adherence to antihypertensive medication include: being aged 18–59 years (PR = 1.23; 95% CI = 1.06–1.47), having a low education level (PR = 1.17; 95% CI = 1.09–1.27), lacking health insurance (PR = 1.26; 95% CI = 1.18–1.36), smoking (PR = 1.12; 95% CI = 1.04–1.21), and lacking knowledge related to antihypertensive medication (PR = 1.88; 95% CI = 1.72–1.97). Conclusion: The government needs to enhance health education and emphasize the importance of regularly taking antihypertensive medication, even when no symptoms are present. Additionally, cross-sector collaboration is necessary to support the prevention of non-adherence to antihypertensive medication.
S-12011
Depok : FKM-UI, 2025
S1 - Skripsi Pusat Informasi Kesehatan Masyarakat
☉
Rifqatul Muthiah Amran; Pembimbing: Hasbullah Thabrany; Penguji: Mardiati Nadjib, Amal Chalik Sjaaf, Helsy Pahlemy, Ihsanil Husna
Abstrak:
ABSTRAK Prevalensi hipertensi di Indonesia terus meningkat dari 21,2% pada tahun 2010 menjadi 23,3% pada tahun 2014. Hipertensi dapat menyebabkan penyakit jantung koroner, stroke, dan kematian jika tidak terdeteksi dini dan diobati secara tepat. Antihipertensi yang efektif dalam menurunan tekanan darah dan mengurangi resiko kejadian penyakit jantung koroner adalah Valsartan dan Amlodipine. Biaya pengobatan selalu menjadi penghalang untuk pengobatan yang efektif. Oleh karena itu, perlu dilakukan kendali mutu dan kendali biaya. Tujuan penelitian ini untuk menganalisis evaluasi ekonomi dengan mengetahui gambaran biaya dan outcome dari penggunaan Valsartan dan Amlodipine selama tiga bulan pengobatan pada pasien hipertensi primer dengan tekanan darah stage I. Penelitian ini bersifat observasional dengan teknik pengambilan data secara retrospektif pada tahun 2016. Outcome berupa rata-rata penurunan tekanan darah sistolik dan diastolik, proporsi tekanan darah terkontrol, dan proporsi tekanan darah tidak terkontrol. Biaya yang diambil dari perspektif pasien yang berupa biaya langsung medis. Hasil penelitian diperoleh bahwa biaya penggunaan Amlodipine lebih rendah (Rp 872.666,02) dibandingkan Valsartan (Rp 1.064.621,00). Rata-rata penurunan tekanan darah pada penggunaan Amlodipine sebesar 16,33 / 7,88 mmHg, sedangkan pada Valsartan sebesar 14,05 / 5,00 mmHg. Proporsi tekanan drah terkontrol pada Amlodipine sebesar 80%, dengan proporsi kejadian penyakit jantung coroner sebesar 27,5%. Sedangkan proporsi tekanan darah terkontrol pada Valsartan 60%, dengan proporsi kejadian penyakit jantung koroner sebesar 72,5%. Pada diagram efektivitas biaya, Amlodipine terletak pada kuadran II dan Valsartan pada kuadran IV. Sehingga dapat disimpulkan bahwa, Amlodipine dominan terhadap Valsartan karena membutuhkan biaya yang lebih rendah dan menghasilkan outcome yang lebih baik. Kata Kunci: Hipertensi Primer, Amlodipine, Valsartan, Evaluasi Ekonomi Background: The prevalence of hypertension in Indonesia continues to increase from 21.2% in 2010 to 23.3% in 2014. Hypertension can lead to coronary heart disease, stroke, and death if not detected early and treated appropriately. Antihypertensives that effectively reducing blood pressure and reducing the risk of coronary heart disease are Valsartan and Amlodipine. Medical expenses have always been a barrier to effective treatment. Therefore, it is necessary to have quality control and cost control.The aims of this study was to analyze economic evaluation and to know the costs and outcomes of use of Valsartan and Amlodipine during three months of treatment in primary hypertension patients with stage I blood pressure. Methods: This study was observational study with retrospective data retrieval technique in 2016. The outcome was the mean reduction of systolic and diastolic blood pressure, the proportion of controlled and uncontrolled blood pressure. Costs taken from the patient's perspective in the form of direct medical costs. Results: The results obtained that the cost of using Amlodipine is lower (Rp 872.666.02) than Valsartan (Rp 1,064,621.00). The mean reduction of blood pressure of Amlodipine was 16.33 / 7.88 mmHg, while Valsartan was 14.05 / 5.00 mmHg. Proportion of controlled blood pressure of Amlodipine was 80%, with a proportion of coronary heart disease events was 27.5%. While the proportion of controlled blood pressure of Valsartan was 60%, with the proportion of coronary heart disease events was 72.5%. In the costeffectiveness diagram, Amlodipine was in quadrant II and Valsartan was in quadrant IV. Conclusion: Amlodipine is dominant against Valsartan because it requires lower cost and better outcome. Key words: Primary Hypertension, Amlodipine, Valsartan, Economic Evaluation
Read More
T-5312
Depok : FKM-UI, 2018
S2 - Tesis Pusat Informasi Kesehatan Masyarakat
☉
Anastasha Cassandra Ko; Pembimbing: Rizka Maulida; Penguji: Lhuri Dwianti Rahmartani, Diah Satyani Saminarsih
Abstrak:
Read More
Penyakit tidak menular (PTM) menyebabkan 71% kematian global, dengan kasus hipertensi diproyeksikan meningkat dari 639 juta pada 2000 menjadi 1,5 miliar pada 2025. Di Indonesia, prevalensi hipertensi meningkat dan menjadi penyebab kematian utama ketiga, namun hanya kurang dari 10% penderita yang memiliki kontrol tekanan darah baik. Penelitian ini menganalisis hubungan karakteristik pasien hipertensi dengan konsumsi obat antihipertensi pada responden Riskesdas 2018. Desain penelitian cross-sectional ini menggunakan data Riskesdas 2018 dengan responden berusia 18 tahun ke atas. Survei oleh Kementerian Kesehatan RI menggunakan stratified multistage random sampling untuk representasi nasional. Karakteristik pasien yang dianalisis meliputi jenis kelamin, kelompok umur, pendidikan, pekerjaan, dan tempat tinggal. Analisis statistik chi-square bivariat dengan signifikansi p < 0.05 digunakan untuk menentukan hubungan tersebut. Tujuan penelitian ini adalah mengidentifikasi karakteristik pasien hipertensi yang signifikan terkait konsumsi obat antihipertensi guna merancang intervensi pengendalian hipertensi yang lebih efektif. Hasil analisis menunjukkan bahwa responden perempuan (OR = 0,78; 95%CI= 0,75-0,81), kelompok umur berisiko (≥31 tahun) (OR = 0,32; 95%CI= 0,30-0,35), individu dengan pendidikan rendah (OR = 1,27; 95%CI=1,22-1,33), tidak bekerja (OR = 1,30; 95%CI= 1,26-1,35), dan tinggal di perdesaan (OR = 0,95; 95%CI= 0,92-0,99) berhubungan dengan konsumsi obat antihipertensi. Temuan ini menekankan perlunya peningkatan kesadaran dan kepatuhan terhadap pengobatan antihipertensi terutama di kalangan kelompok berisiko tinggi, untuk mengurangi beban hipertensi di Indonesia.
Non-communicable diseases (NCDs) account for 71% of global deaths, with hypertension cases projected to increase from 639 million in 2000 to 1.5 billion by 2025. In Indonesia, the prevalence of hypertension is rising and is the third leading cause of death, but less than 10% of patients have good blood pressure control. This study analyzes the relationship between the characteristics of hypertensive patients and the consumption of antihypertensive drugs among respondents of the 2018 Riskesdas. This cross-sectional study design uses data from the 2018 Riskesdas with respondents aged 18 years and older. The survey by the Indonesian Ministry of Health used stratified multistage random sampling for national representation. The analyzed patient characteristics include gender, age group, education, occupation, and place of residence. Bivariate chi-square statistical analysis with significance set at p < 0.05 was used to determine these relationships. The aim of this study is to identify significant characteristics of hypertensive patients related to the consumption of antihypertensive drugs to design more effective hypertension control interventions. The analysis results show that female respondents (OR = 0.78; 95%CI = 0.75-0.81), at-risk age group (≥31 years) (OR = 0.32; 95%CI = 0.30-0.35), individuals with low education (OR = 1.27; 95%CI = 1.22-1.33), unemployed (OR = 1.30; 95%CI = 1.26-1.35), and living in rural areas (OR = 0.95; 95%CI = 0.92-0.99) are associated with the consumption of antihypertensive drugs. These findings highlight the need to increase awareness and adherence to antihypertensive treatment, especially among high-risk groups, to reduce the burden of hypertension in Indonesia.
S-11782
Depok : FKM UI, 2024
S1 - Skripsi Pusat Informasi Kesehatan Masyarakat
☉
Wina Adelia Putri; Pembimbing: Besral; Penguji: Milla Herdayati, Zakiah
Abstrak:
Latar Belakang: Hipertensi merupakan salah satu beban kesehatan masyarakat terbesar di Indonesia dan pemicu utama penyakit kardiovaskular. Keberhasilan pengendalian kondisi hipertensi sangat bergantung pada kepatuhan pasien. Berdasarkan data SKI 2023, ketidakpatuhan minum obat antihipertensi masih menjadi masalah signifikan di Indonesia. Metode: Menggunakan data sekunder dari SKI 2023 dengan desain studi cross sectional. Sampel adalah responden berusia ≥18 tahun dengan diagnosis hipertensi. Responden dengan data tidak lengkap dan wanita hamil diesklusi sehingga menghasilkan sampel akhir sebanyak 49.026 responden. Analisis data menggunakan regresi logistik multinomial. Hasil: Seluruh variabel independen yang diuji (pendidikan, pekerjaan, status ekonomi, wilayah geografis, komorbiditas, waktu sejak diagnosis, umur, jenis kelamin, tempat tinggal, perilaku penggunaan obat tradisional, konsumsi alkohol, akses fasilitas kesehatan, kepemilikan asuransi, dan dukungan informasi) berhubungan signifikan dengan ketidakpatuhan. Persentase ketidakpatuhan adalah sebesar 53,5%, yaitu 36,7% (95% CI: 35,9-37,4) responden tidak rutin dan 16,8% (95% CI: 16,2-17,4) tidak minum obat. AOR tertinggi ditemukan pada responden yang tidak mendapatkan dukungan informasi, baik pada kategori tidak rutin (AOR 3,76; 95% CI 3,59-3,95; p<0,001) dan pada kategori tidak minum obat (AOR 8,63; 95% CI: 8,12-9,19; p<0,001). Kesimpulan: Ketidakpatuhan minum obat antihipertensi masih menjadi tantangan besar di Indonesia. Diperlukan intervensi berbasis komunitas, peningkatan edukasi, dan perbaikan akses kesehatan untuk meningkatkan kepatuhan terhadap pengobatan.
Background: Hypertension is one of the largest public health burdens in Indonesia and a major trigger for cardiovascular disease. The success of controlling hypertension is highly dependent on patient compliance. Based on SKI 2023 data, non-compliance with taking antihypertensive drugs is still a significant problem in Indonesia. Methods: Using secondary data from SKI 2023 with a cross-sectional study design. The sample was respondents aged ≥18 years with a diagnosis of hypertension. Respondents with incomplete data and pregnant women were excluded, resulting in a final sample of 49,026 respondents. Data analysis used multinomial logistic regression. Results: All independent variables tested (education, occupation, economic status, geographic region, comorbidities, time since diagnosis, age, gender, place of residence, traditional medicine use behavior, alcohol consumption, access to health facilities, insurance ownership, and information support) were significantly associated with non-compliance. The percentage of non-compliance was 53.5%, specifically 36.7% (95% CI: 35.9-37.4) of respondents did not follow the routine, and 16.8% (95% CI: 16.2-17.4) did not take their medication. The highest AOR was found in respondents who did not receive information support, both in the non-routine category (AOR 3.76; 95% CI 3.59-3.95; p<0.001) and in the category of not taking medication (AOR 8.63; 95% CI: 8.12-9.19; p<0.001). Conclusion: Non-compliance with taking antihypertensive medication is still a major challenge in Indonesia. Community-based interventions, increased education, and improved access to health are needed to improve treatment adherence.
Read More
Background: Hypertension is one of the largest public health burdens in Indonesia and a major trigger for cardiovascular disease. The success of controlling hypertension is highly dependent on patient compliance. Based on SKI 2023 data, non-compliance with taking antihypertensive drugs is still a significant problem in Indonesia. Methods: Using secondary data from SKI 2023 with a cross-sectional study design. The sample was respondents aged ≥18 years with a diagnosis of hypertension. Respondents with incomplete data and pregnant women were excluded, resulting in a final sample of 49,026 respondents. Data analysis used multinomial logistic regression. Results: All independent variables tested (education, occupation, economic status, geographic region, comorbidities, time since diagnosis, age, gender, place of residence, traditional medicine use behavior, alcohol consumption, access to health facilities, insurance ownership, and information support) were significantly associated with non-compliance. The percentage of non-compliance was 53.5%, specifically 36.7% (95% CI: 35.9-37.4) of respondents did not follow the routine, and 16.8% (95% CI: 16.2-17.4) did not take their medication. The highest AOR was found in respondents who did not receive information support, both in the non-routine category (AOR 3.76; 95% CI 3.59-3.95; p<0.001) and in the category of not taking medication (AOR 8.63; 95% CI: 8.12-9.19; p<0.001). Conclusion: Non-compliance with taking antihypertensive medication is still a major challenge in Indonesia. Community-based interventions, increased education, and improved access to health are needed to improve treatment adherence.
S-11968
Depok : FKM-UI, 2025
S1 - Skripsi Pusat Informasi Kesehatan Masyarakat
☉
Dhea Synthia; Pembimbing: Tri Krianto; Penguji: Syahrizal Syarif, Trisari Anggondowati, Hidayat Nuh Ghazali Djadjuli
Abstrak:
Read More
Kepatuhan minum obat antihipertensi menjadi prioritas teratas dalam efektifitas pengobatan penderita hipertensi. Ketidakpatuhan dalam pengobatan berisiko membuat tekanan darah tidak terkontrol. Penelitian ini bertujuan untuk mengetahui determinan kepatuhan minum obat antihipertensi pada penderita hipertensi di Kota Depok. Penelitian ini menggunakan desain cross sectional dengan populasi penderita hipertensi di Kota Depok dan jumlah sampel sebanyak 185 orang yang diambil menggunakan teknik cluster sampling. Data dikumpulkan dengan cara pengisian kuesioner oleh responden dan dianalisis secara univariat, bivariat, dan multivariat. Hasil penelitian menunjukkan bahwa 54,1% penderita hipertensi di Kota Depok terkategori tidak patuh minum obat antihipertensi. Persepsi individu dan faktor predisposisi yang berhubungan dengan kepatuhan minum obat antihipertensi diantaranya persepsi kerentanan, keseriusan, manfaat, hambatan, efikasi diri, isyarat untuk bertindak, usia, pengetahuan dan sikap tentang hipertensi dan kepatuhan minum obat antihipertensi. Efikasi diri menjadi faktor paling dominan berhubungan dengan perilaku kepatuhan minum obat antihipertensi (OR:2,63; 95%CI:1,055-6,563) dengan hasil penderita hipertensi yang memiliki efikasi diri rendah berisiko 2,6 kali untuk berperilaku tidak patuh minum obat antihipertensi. Oleh karena itu, perlu adanya pengembangan pelatihan guna meningkatkan efikasi diri penderita hipertensi seperti keterampilan mengelola kesehatan, manajemen stress, dan adanya kelompok pendukung.
Adherence to taking antihypertensive medication is the top priority in the effective treatment of hypertension patients. Non-adherence risks causing uncontrolled blood pressure. This study aims to determine the determinants of adherence to taking antihypertensive medication in patients with hypertension in Depok City. It used a cross-sectional design with a population of hypertensive patients in Depok City and a sample size of 185 people taken using cluster sampling. Data were collected through questionnaires filled out by respondents and analyzed univariately, bivariately, and multivariately. The results showed that 54,1% of hypertensive patients in Depok City were categorized as non-adherent to taking antihypertensive drugs. Individual perceptions and predisposing factors associated with adherence include perceived susceptibility, severity, benefits, barriers, self-efficacy, cues to action, age, knowledge, and attitudes about hypertension. Self-efficacy is the most dominant factor associated with antihypertensive medication adherence behavior (OR: 2,63; 95% CI: 1,055–6,563), with hypertensive patients with low self-efficacy being 2,6 times more likely to exhibit non-adherent behavior. Therefore, it is necessary to develop training to increase self-efficacy in hypertensive patients, such as health management skills, stress management, and support groups.
T-7227
Depok : FKM UI, 2025
S2 - Tesis Pusat Informasi Kesehatan Masyarakat
☉
Nurul Aliyah; Pembimbing: Tri Krianto; Penguji: Siti Arifah Pujonarti, Syahrizal, Anita Rahmiwati, Yudhi Setiawan
Abstrak:
Read More
Masalah ketidakpatuhan dalam pengobatan sering dijumpai pada penyakit yang memerlukan penanganan jangka panjang, seperti hipertensi. Ketidakpatuhan terhadap pengobatan hipertensi sering kali menjadi penyebab utama berbagai kecacatan. Alasan utama yang mendasari ketidakpatuhan minum obat pada pasien hipertensi tersebut ialah kurangnya pengetahuan pasien akan pentingnya minum obat hipertensi secara teratur. Penelitian ini bertujuan untuk mengetahui faktor-faktor yang berhubungan dengan kepatuhan minum obat antihipertensi penderita hipertensi di Puskesmas Boom baru Kota Palembang berdasarkan teori Lawrence Green. Penelitian ini menggunakan desain cross sectional dengan 102 sampel. Jumlah sampel dihitung dengan rumus Lemeshow dan sampel diambil secara purposive sampling sesuai dengan kriteria inklusi dan eksklusi. Data dikumpulkan dengan wawancara menggunakan kuesioner yang dianalisis secara univariat, bivariat dan multivariat. Hasil penelitian menunjukkan 74 responden (72,5%) patuh dalam minum obat antihipertensi. Faktor-faktor yang berhubungan dengan kepatuhan minum obat antihipertensi meliputi pengetahuan, sikap, motivasi diri, dukungan keluarga dan dukungan tenaga kesehatan. Faktor yang paling dominan berhubungan dengan kepatuhan minum obat antihipertensi, adalah pengetahuan dengan nilai OR = 8,040 (95% CI: 2,151 - 30,050). Perlu dilakukan upaya peningkatan pengetahuan, sikap, motivasi dengan menyediakan media informasi melalui media sosial seperti membuat grup whatsapp sebagai media komunikasi secara daring antara penderita hipertensi dan tenaga kesehatan di Puskesmas Boom baru dan sebagai media penyebaran informasi sebagai upaya peningkatan pengetahuan. Edukasi diperlukan dengan menitikberatkan pada pengetahuan mengenai hipertensi dan tatalaksananya. Juga perlu dilakukan langkah pendekatan dengan keluarga sebagai upaya untuk menjalin kerjasama antara tenaga kesehatan dan keluarga dalam memberikan dukungan bagi penderita hipertensi.
The problem of non-adherence medication is often encountered in diseases that require long-term management, such as hypertension. Non-adherence among hypertension medication is often become as main cause of various disabilities. The main reason underlying of the non-adherence medication among hypertension patients are the lack of patients knowledges of the importance of taking hypertension medication regularly. This study aims to determine the factors associated with adherence to taking antihypertension medication among hypertension patients who regularly seek treatment at the Boom Baru Public Health Centre, Palembang City based on Lawrence Green's theory. This study used a cross sectional design with 102 samples. The number of samples was calculated using the Lemeshow and the samples were taken by purposive sampling according to the inclusion and exclusion criterias. Datas were collected by interview using a questionnaire which was analysed univariately, bivariately and multivariately. The results showed that 74 respondents (72.5%) were compliant in taking antihypertension medication. Factors associated with adherence on taking antihypertension medication includes knowledge, attitude, self-motivation, family support and health worker support. The most dominant factor associated with adherence to taking antihypertension drug is knowledge with OR = 8,040 (95% CI: 2,151 - 30,050). Efforts need to be made to improve knowledge, attitudes, motivation by providing information media through social media such as creating a WhatsApp group as an online communication medium between hypertension patients and health workers at Puskesmas Boom Baru and as a medium for disseminating information as an effort to increase knowledge. Education is needed with an emphasis on knowledge about hypertension and its management. It is also necessary to take steps to approach families as an effort to establish cooperation between health workers and families in providing support for people with hypertension.
T-6954
Depok : FKM UI, 2024
S2 - Tesis Pusat Informasi Kesehatan Masyarakat
☉
Debby Daniel, Setianti Haryani
BIKF Vol.1, No.2
Jakarta : RS Fatmawati, 1999
Indeks Artikel Jurnal-Majalah Pusat Informasi Kesehatan Masyarakat
☉
Wantoro; Pembimbing: Ratna Djuwita
S-2544
Depok : FKM UI, 2002
S1 - Skripsi Pusat Informasi Kesehatan Masyarakat
☉